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Vibrio cholerae in Traveler  
from Haiti to Canada  
To the Editor: A nationwide outbreak of cholera caused by Vibrio cholerae O1 serotype 
Ogawa began in Haiti in October 2010 and has since resulted in >200,000 illnesses and 4,000 
deaths (1). Additional cases of cholera attributed to the outbreak strain have subsequently been 
reported in the neighboring Dominican Republic and in Florida and New Jersey in the United 
States. In these instances, illness was related to travel to Haiti or consumption of contaminated 
water on the island of Hispaniola (which is shared by Haiti and Dominican Republic). 
In Canada, the province of Québec has a large Haitian immigrant population. In early 
November 2010, the Québec public health authorities provided clinicians and laboratories with 
recommendations regarding the diagnosis of V. cholerae infections. We report a case of V. 
cholerae O1 serotype Ogawa in Canada related to the outbreak in Haiti. It was diagnosed in 
Montréal, Québec, on January 5, 2011. 
A 49-year-old Canadian woman traveled to Haiti with her 5 brothers and sisters during 
December 22–29, 2010, to attend her mother’s funeral. While in Haiti, they stayed with family 
members. She came to the emergency department of the Centre Hospitalier de l’Université de 
Montréal on January 1, 2011, with abdominal cramps and diarrhea of moderate intensity that had 
started on December 29, the day she returned from Haiti. The patient was asthenic, but vital 
signs and results of a physical examination were normal. A complete blood count, levels of 
serum electrolytes and serum creatinine, and results of liver function tests were within reference 
ranges. A fecal sample was submitted and the patient received intravenous fluids and 1 dose (300 
mg) of doxycycline. She improved rapidly and was discharged on January 3. The patient 
returned to the outpatient clinic on January 7, and she had recovered from her illness. Control 
fecal specimens obtained on January 9 and 10 were negative for V. cholerae. Family members Page 2 of 4 
that traveled with her did not get ill, and there were no secondary cases among her family 
members in Montréal. 
The fecal culture of the sample provided on December 29 contained V. cholerae. The 
isolate was confirmed as toxigenic V. cholerae serogroup O1, serotype Ogawa, biotype El Tor, 
and matched the Haiti outbreak strain when tested by pulsed-field gel electrophoresis (PFGE). 
Antimicrobial drug susceptibility testing was performed by continuous gradient dilution (Etest), 
and results were interpreted according to standard criteria (2). The strain was susceptible to 
azithromycin (0.25 mg/L), ciprofloxacin (0.5 mg/L), and tetracycline (1 mg/L) and resistant to 
trimethoprim/sulfamethoxazole (>32/608 mg/L). 
Cases of diagnosed cholera are rare in Canada (0–3 laboratory-confirmed isolations of 
serogroup O1 and O139 V. cholerae per year (3). All cases in Canada have been associated with 
travel to cholera-endemic areas, including Africa and Southeast Asia. Monitoring of cholera in 
Canada is completed through the National Notifiable Diseases Program and through the public 
health laboratory network. Biochemical identification, serotyping, and PFGE testing are 
performed on all suspected V. cholerae isolates. Confirmed isolations of a serogroup O1 or O139 
V. cholerae strain that produces cholera toxin are also reported through the International Health 
Regulations focal point. 
Whole genome sequencing has been completed for several isolates to investigate the 
origin of the Haiti cholera outbreak (4,5). However, PFGE remains one of the primary tools for 
defining the outbreak strain (4). The highly standardized methods of PulseNet International for 
generating, analyzing, and comparing PFGE patterns are used worldwide to track the temporal 
and geographic distribution of V. cholerae (6,7). 
PFGE for V. cholerae was performed by using restriction enzymes SfiI and NotI (8). The 
PFGE patterns of this travel-associated case matched patterns of the representative Haiti cholera 
outbreak strain that was deposited into the American Type Culture Collection (Manassas, VA, 
USA) by the Centers for Disease Control and Prevention (Atlanta, GA, USA; strain BAA-2163; 
CDC isolate 2010EL-1786) (Figure). PulseNet Canada SfiI and NotI PFGE pattern designations 
were VCSFI.0006 and VCNTI.0006, respectively, and were equivalent to PulseNet USA patterns 
KZGS12.0088 and KZGN11.0092. Page 3 of 4 
Prevention, treatment and control efforts are currently under way in Haiti. Loss of 
infrastructure during the earthquake of January 12, 2010, has affected implementation of 
sanitation and public health measures. Travel advisories and travel health precautions were 
subsequently released, including those from Canada and United States (9,10). These precautions 
recommended that preventative measures such as vaccination and safe food and water 
consumption practices be adhered to by residents and visitors to affected regions. Although the 
public health community anticipated that travel-associated cases would be diagnosed in Québec, 
this report of a documented case (supported by laboratory and epidemiologic data) emphasizes 
the domestic and international public health risk caused by the nationwide outbreak in Haiti. It 
also illustrates the need for an accurate travel history in clinical and laboratory diagnosis of 
cholera infections. 
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Figure. Pulsed-field gel electrophoresis of cholera outbreak strain from Haiti and travel-associated isolate 
in the patient, by using SfiI and NotI and PulseNet Canada pulsed-field gel electrophoresis pattern 
designations. 